The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Upper tract urothelial carcinoma is non-basal and T-cell depleted.
 
Panagiotis J. Vlachostergios
No Relationships to Disclose
 
Brian D. Robinson
Stock and Other Ownership Interests - Metastat
Consulting or Advisory Role - Progenics
Patents, Royalties, Other Intellectual Property - methods for diagnosing and treating prostate cancer
 
Bhavneet Bhinder
No Relationships to Disclose
 
Rohan Bareja
No Relationships to Disclose
 
Kyung Park
No Relationships to Disclose
 
Peyman Tavassoli
No Relationships to Disclose
 
Scott T. Tagawa
Consulting or Advisory Role - Abbvie; Astellas Pharma; Bayer; Dendreon; Endocyte; Genentech; Immunomedics; Janssen; Karyopharm Therapeutics; Medivation; Sanofi; Tolmar
Speakers' Bureau - Amgen
Research Funding - Abbvie (Inst); Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); AVEO (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Clovis Oncology (Inst); Dendreon (Inst); Endocyte (Inst); Exelixis (Inst); Genentech (Inst); Immunomedics (Inst); Inovio Pharmaceuticals (Inst); Janssen (Inst); Karyopharm Therapeutics (Inst); Lilly (Inst); Medivation (Inst); Merck (Inst); Millennium (Inst); Newlink Genetics (Inst); Novartis (Inst); Progenics (Inst); Rexahn Pharmaceuticals (Inst); Sanofi (Inst); Stem CentRx (Inst)
Travel, Accommodations, Expenses - Immunomedics; Sanofi
 
David M. Nanus
Consulting or Advisory Role - Roche/Genentech
 
Juan Miguel Mosquera
No Relationships to Disclose
 
Douglas Scherr
No Relationships to Disclose
 
Mark A. Rubin
Research Funding - Janssen; Lilly
 
Olivier Elemento
No Relationships to Disclose
 
Bishoy Faltas
No Relationships to Disclose